Research
(NPR) ICAP’s Jessica Justman Speaks to the Potential of Convalescent Plasma Treatment Therapies
ICAP’s Jessica Justman, MD, senior technical director, remains hopeful in the potential benefits of convalescent plasma as treatment for patients with COVID-19. She recently spoke to NPR on the role the treatment could play in the global pandemic response:...
New PrEP Study Shows Significant Results for HIV Prevention
Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing long-acting cabotegravir (CAB LA) injected once every eight weeks was superior to daily oral...
ICAP Research Contributes to Detailed Maps of the HIV Epidemic
A new study co-authored by Jessica Justman, MD, Senior Technical Director at ICAP at Columbia University and Associate Professor of Medicine in Epidemiology at Columbia’s Mailman School of Public Health, captures the evolution and variation of the HIV epidemic over...

